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Abstract
Background: Sweet taste receptor is expressed in the taste buds and enteroendocrine cells acting as a sugar sensor. We
investigated the expression and function of the sweet taste receptor in MIN6 cells and mouse islets.
Methodology/Principal Findings: The expression of the sweet taste receptor was determined by RT–PCR and
immunohistochemistry. Changes in cytoplasmic Ca
2+ ([Ca
2+]c) and cAMP ([cAMP]c) were monitored in MIN6 cells using
fura-2 and Epac1-camps. Activation of protein kinase C was monitored by measuring translocation of MARCKS-GFP. Insulin
was measured by radioimmunoassay. mRNA for T1R2, T1R3, and gustducin was expressed in MIN6 cells. In these cells,
artificial sweeteners such as sucralose, succharin, and acesulfame-K increased insulin secretion and augmented secretion
induced by glucose. Sucralose increased biphasic increase in [Ca
2+]c. The second sustained phase was blocked by removal of
extracellular calcium and addition of nifedipine. An inhibitor of inositol(1, 4, 5)-trisphophate receptor, 2-aminoethox-
ydiphenyl borate, blocked both phases of [Ca
2+]c response. The effect of sucralose on [Ca
2+]c was inhibited by gurmarin, an
inhibitor of the sweet taste receptor, but not affected by a Gq inhibitor. Sucralose also induced sustained elevation of
[cAMP]c, which was only partially inhibited by removal of extracellular calcium and nifedipine. Finally, mouse islets
expressed T1R2 and T1R3, and artificial sweeteners stimulated insulin secretion.
Conclusions: Sweet taste receptor is expressed in b-cells, and activation of this receptor induces insulin secretion by Ca
2+
and cAMP-dependent mechanisms.
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Introduction
Molecular identification of the sweet taste receptor has
provided new and precise insights into our understanding of
the taste sensation [1–4]. The sweet taste receptor is a
heterodimer of T1R2 and T1R3, both of which belong to a
subclass of G-protein-coupled receptors resembling metabotropic
glutamate receptor (mGluR), calcium-sensing receptor and
pheromone receptors (V2R). Members of this subclass have large
extracellular amino-terminal domains which bind most of the
ligands to this region. Based on structural similarity with
mGluR1, binding of ligands is thought to stabilize the active
form of the sweet receptor by binding them within the cleft.
Indeed, the sweet taste receptor is activated by various types of
sweet substances including glucose, sucrose, fructose, artificial
sweeteners including saccharin and acesulfame-K, and even
proteins such as monellin and thaumatin [5,6]. Most of them are
small molecules but some are much larger in size. It is thought
that various types of sweeteners bind to different portions of the
receptor, stabilize by different manners, and activate the bc
subunit of the trimeric G protein, which subsequently activates
phospholipase C-b (PLC-b) (5, 6).
In addition to the taste cells in the tongue, the sweet taste
receptor is also expressed in intestinal epithelial cells, in particular,
in enteroendocrine cells [7]. Margolskee, et al. [8] recently showed
that the sweet taste receptor expressed in enteroendocrine cells
regulates the expression of sodium-dependent glucose transporter-
1 (SGLT1), which is expressed in enterocytes. Activators of the
sweet taste receptor including dietary sugar and artificial
sweeteners activate the sweet taste receptor expressed in
enteroendocrine cells and induce secretion of glucagon-like
peptide-1 and glucose-dependent insulinotropic peptide, both of
which stimulate the expression of SGLT1 in enterocytes. These
observations clearly demonstrate that the sweet taste receptor
functions as a sugar sensor in tissues other than taste buds in the
tongue.
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5106In this regard, pancreatic b-cells are originated from endoderm
and resemble enteroendocrine cells in many respects [9,10]. More
importantly, these cells respond to fuels, especially sugars,
including glucose and secrete insulin, a primary regulator of the
glucose metabolism in the body. It is now generally accepted that
the glucose-sensing machinery in b-cells is dependent on glucose
metabolism [11], and molecules such as glucokinase and ATP-
sensitive potassium channel are important for glucose sensing.
Nevertheless, given that the sweet taste receptor is a key molecule
in sugar sensing, it is interesting to address whether or not the
sweet taste receptor is expressed in b cells. In the present study, we
examined whether or not the sweet taste receptor is expressed in
pancreatic b-cells. We also investigated the function of this
receptor using MIN6 cells.
Results
Expression of the Sweet Taste Receptor in MIN6 Cells
We first examined whether or not the sweet taste receptor is
expressed in MIN6 cells. As shown in Figure 1A, mRNA for T1R2
and T1R3 was detected by RT-PCR. In addition, mRNA for
gustducin was also expressed in MIN6 cells. We then examined
the expression of the sweet taste receptor by immunohistochem-
istry. Immunoreactivities of T1R2 and T1R3 were detected in
MIN6 cells (Figure 1B). T1R3 signal was stronger and punctated.
Effect of Artificial Sweeteners on Insulin Secretion in
MIN6 Cells
To determine the function of the sweet taste receptor expressed
in MIN6 cells, we examined whether artificial sweeteners affected
insulin secretion. As shown in Figure 2A, sucralose stimulated
insulin secretion in the presence of a low concentration of glucose.
Likewise, saccharin stimulated insulin secretion and acesulfame-K
was much more potent. Note that 50 mM mannitol did not affect
insulin secretion (data not shown). Saccharin and acesulfame-K
also increased insulin secretion induced by a high concentration of
glucose. Figure 2B depicts the dose-response relationship of the
sucralose effect. The effect of sucralose was evident at a
concentration of 50 mM. As shown in Figure 2C, sucralose
augmented glucose-induced insulin secretion. Hence, agonists of
the sweet taste receptor in the taste buds of the tongue were able to
induce insulin secretion from MIN6 cells.
Changes in Cytoplasmic Ca
2+ and cAMP Concentrations
To investigate the intracellular signaling system activated by
the sweet taste receptor, we measured the effects of sucralose on
[Ca
2+]c and [cAMP]c. We monitored [Ca
2+]c and [cAMP]c
simultaneously using fura-2 and Epac1-camps. As shown in
Figure 3A, sucralose induced increases in both [Ca
2+]c and
[cAMP]c. Sucralose actually induced biphasic elevation of
[Ca
2+]c. The initial rapid peak was followed by a gradual
decrease in [Ca
2+]c, and [Ca
2+]c remained slightly elevated for a
long period. The effect of sucralose was dose-dependent and
detected at a concentration of 10 mM (Figure 3B). Note that the
effect of sucralose on [Ca
2+]c was not affected by diazoxide, an
opener of the ATP-sensitive potassium channel (data not shown).
The patterns of changes in [Ca
2+]c and [cAMP]c were quite
different from that induced by the high concentration of glucose
(Figure 3C). As depicted, 25 mM glucose increased [Ca
2+]c after
a lag period of 2 to 5 min, which was accompanied by an
Figure 1. Expression of the sweet taste receptor in MIN6 cells. (A) Expression of mRNA for T1R2, T1R3 and a subunit of gustducin (Gagust)i n
MIN6 cells was measured by RT-PCR. MM: molecular markers. The result is a representative of three experiments. (B) MIN6 cells were stained by anti-
T1R2 (a) and anti-T1R3 (b) antibodies.
doi:10.1371/journal.pone.0005106.g001
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from that induced by carbachol, a muscarinic agonist which
activates PLC-b. As depicted in Figure 3D, carbachol induced a
transient increase in [Ca
2+]c. In contrast, [cAMP]c was reduced
by carbachol. We then examined the involvement of the sweet
taste receptor in the action of sucralose. As shown in Figure 4A,
3 mg/ml gurmarin, an inhibitor of the sweet taste receptor in the
taste buds [12] attenuated sucralose-induced elevation of [Ca
2+]c.
Quantitatively, the effect of gurmarin was statistically significant
(Figure 4B). Higher concentration of gurmarin did not further
inhibit the sucralose action. Gurmarin did not affect [cAMP]c
response to sucralose (data not shown). We then examined the
Figure 2. Effect of artificial sweeteners on insulin secretion in MIN6 cells. (A) MIN6 cells were incubated for 60 min with or without 50 mM
saccharin, 50 mM sucralose or 50 mM acesulfame-K in the presence of 3 or 25 mM glucose, and insulin secretion was measured. Values are expressed
as means6S.E. for four experiments. *: P,0.05 vs 3 mM glucose, **: P,0.05 vs 25 mM glucose. Note that 50 mM mannitol did not affect insulin
secretion. (B) MIN6 cells were incubated for 60 min with 0, 1, 10 or 50 mM sucralose in the presence of 3 mM glucose, and insulin secretion was
measured. Values are expressed as mean6S. E. for four experiments. *: P,0.05 vs 3 mM glucose alone. (C) MIN6 cells were incubated for 60 min with
3, 8.3 or 25 mM glucose in the presence (N) and absence (#) of 50 mM sucralose. Values are expressed as mean6S. E. for four experiments. *: P,0.05
vs without sucralose.
doi:10.1371/journal.pone.0005106.g002
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Figure 4C, YM254890, an inhibitor of Gq/11 [13], barely
inhibited the elevation of [Ca
2+]c and [cAMP]c induced by
sucralose. In contrast, the effects of carbachol on [Ca
2+]c and
[cAMP]c were completely blocked by YM254890 (Figure 4D).
We then examined the dependency of [Ca
2+]c and [cAMP]c
responses on extracellular calcium. As shown in Figure 5A,
removal of extracellular calcium markedly reduced the [Ca
2+]c
response to sucralose. In the absence of extracellular calcium, the
effect of sucralose on [Ca
2+]c was small and only transient.
Furthermore, the effect of sucralose on [cAMP]c was attenuated.
Similarly, [Ca
2+]c response to sucralose was markedly inhibited
by nifedipine, an inhibitor of the L-type voltage-dependent
calcium channel. Again, nifedipine also reduced elevation of
[cAMP]c induced by sucralose (Figure 5B). When extracellular
sodium was removed, the effect of sucralose on [Ca
2+]c was
greatly reduced (Figure 5C). We also examined the effect of an
inhibitor of inositol(1,4,5)-trisphosphate (Ins-P3) receptor 2-
aminoethoxydiphenyl borate (2APB) [14]. As shown in
Figure 5D, 2APB nearly completely blocked sucralose-induced
Figure 3. Effect of sucralose on [Ca
2+]c and [cAMP]c in MIN6 cells. (A) MIN6 cells expressing Epac1-camps were loaded with fura-2, and
changes in [Ca
2+]c (#) and [cAMP]c (N) were monitored. Cells were stimulated by 50 mM sucralose. Note that 50 mM mannitol did not affect [Ca
2+]c
or [cAMP]c indicating that the effect of sucralose was not simply due to changes in osmolarity. (B) Dose-response relationship for the effect of
sucralose. Cells were stimulated with various concentrations of sucralose, and the area under the curve (AUC) for [Ca
2+]c and [cAMP]c was calculated.
Values are the mean6S.E. for five experiments. (C) Epac1-camps-expressing cells loaded with fura-2 were stimulated with 25 mM glucose, and
changes in [Ca
2+]c (#) and [cAMP]c (N) were monitored. (D) Cells were stimulated with 50 mM carbachol and changes in [Ca
2+]c (#) and [cAMP]c (N)
were monitored.
doi:10.1371/journal.pone.0005106.g003
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2+]c. Both initial and sustained phases of the
[Ca
2+]c response were blocked. In this condition, [cAMP]c
response was also reduced but not blocked completely. Quanti-
tative analyses of the effects of these agents are summarized in
Figure 5E. In the taste buds, artificial sweeteners activate PLC-b2
via gustducin, and resultant elevation of [Ca
2+]c leads to an
activation of TRPM5, which induces sodium entry and
depolarizes the plasma membrane [15]. We therefore examined
the expression of the channels belonging to the TRPM family. As
shown in Figure 5F, TRPM5 was not detected in our
experimental condition. Instead, TRPM4, which resembles
TRPM5 in many respects, and TRPV2 were expressed.
Figure 4. Involvement of the sweet taste receptor in the action of sucralose. (A): Epac1-camps-expressing MIN6 cells loaded with fura-2
were incubated with (#) or without (N)3mg/ml gurmarin for 10 min and then stimulated with 50 mM sucralose. Changes in [Ca
2+]c were monitored.
(B) Quantitative analysis of the effect of gurmarin. Cells were stimulated by 50 mM sucralose in the presence and absence of gurmarin and the AUC
was calculated. Values are the mean6S.E. for four experiments. *: p,0.05 vs none. (C) Epac1-camps-expressing MIN6 cells loaded with fura-2 were
preincubated with 10 mM YM254890 for 10 min and then stimulated with 50 mM sucralose in the presence of YM254890. Changes in [Ca
2+]c (#) and
[cAMP]c (N) were monitored. (D) Epac1-camps-expressing MIN6 cells loaded with fura-2 were preincubated with YM254890 for 10 min and then
stimulated with 50 mM carbachol in the presence (#) and absence (N) of YM254890.
doi:10.1371/journal.pone.0005106.g004
Sweet Taste Receptor in Islet
PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5106Sweet Taste Receptor in Islet
PLoS ONE | www.plosone.org 6 April 2009 | Volume 4 | Issue 4 | e5106Effect of Sucralose on Activation of Protein Kinase C
To determine whether or not sucralose also activates PKC, we
monitored translocation of a PKC substrate MARCKS. As
reported previously, unphosphorylated MARCKS is localized in
the plasma membrane and is released into cytosol when
phosphorylated by PKC [16]. We therefore monitored the
amount of cytosolic MARCKS by measuring the MARCKS-
GFP fluorescence in cytosol. As shown in Figure 6A, addition of
sucralose increased the MARCKS-GFP fluorescence in cytosol.
The effect of sucralose was rapid and sustained for at least 10 min.
In the absence of extracellular calcium, the effect of sucralose on
cytosolic MARCKS was nearly completely inhibited (Figure 6B).
A similar result was obtained by adding nifedipine (data not
shown).
Expression of the Sweet Taste Receptor in Mouse Islets
We then examined the expression of the sweet taste receptor in
mouse islets. As shown in Figure 7A, mRNA for T1R2 and T1R3
was detected in mouse islets. In addition, mRNA for gustducin was
also detected in this condition. Figure 7B shows the comparison of
the expression of T1Rs in islets and MiN6 cells. The expression
levels of mRNA for T1Rs and gustducin were lower in islets
compared to MIN6 cells. As shown in Figure 7C, immunoreac-
tivity of T1R3 was found in insulin-producing b-cells. Immuno-
reactive T1R2 was not detected. To test the function of the sweet
taste receptor, mouse islets were incubated with an artificial
sweetener, sucralose. As depicted in Figure 7D, sucralose induced
insulin secretion from mouse islets.
Discussion
In the present study, we showed that mRNA and protein of the
sweet taste receptor are expressed in pancreatic b-cells and MIN6
insulinoma cells. Also, gustducin, a trimeric GTP-binding protein
coupling the sweet taste receptor and phospholipase C-b2 in the
taste buds, is also expressed in b-cells and MIN6 cells. Thus,
components of the sweet taste receptor signaling system are
present in b-cells. These results are in agreement with a recent
report by Reimann, et al. that mRNA for T1Rs is expressed in
islets [17]. The sweet taste receptor system in b-cells is functional
since several artificial sweeteners, which are known to be sweet
taste receptor agonists in the taste buds, are able to stimulate
insulin secretion from mouse islets as well as MIN6 cells. Hence, in
addition to enteroendocrine cells [8], a functional sweet taste
receptor system is expressed in pancreatic b-cells. Malaisse, et al.
[18] reported that artificial sweeteners such as sodium saccharin,
sodium cyclamate and acesulfame-K increased insulin secretion.
These compounds also display a bitter taste. They postulated that
these agents acted on the bitter taste receptor. In this regard,
bitter-tasting substance denatonium stimulates insulin secretion
[19]. This compound acts directly on Kir6.2 and blocks the ATP-
sensitive potassium channel [19]. Given that sucralose, which does
not display a bitter taste, stimulates insulin secretion, at least some
of the effects of sodium saccharin and acesulfame-K are mediated
by the sweet taste receptor.
In MIN6 cells, sucralose stimulated insulin secretion in the
presence of 3 mM glucose but not in the presence of 25 mM
glucose. In contrast, succharin and acesulfame-K augmented
insulin secretion induced by 25 mM glucose. This could be due to
Figure 6. Effect of sucralose on PKC activation. (A) MIN6 cells
expressing MARCKS-GFP were loaded with fura-2. Cells were stimulated
with 50 mM sucralose and changes in [Ca
2+]c (#) and the amount of
MARCKS-GFP in cytosol (N) were monitored. (B) MIN6 cells expressing
MARCKS-GFP were loaded with fura-2. Cells were then incubated in
Ca
2+-free HBSS and stimulated with 50 mM sucralose and changes in
[Ca
2+]c (#) and amount of MARCKS-GFP in cytosol (N) were measured.
doi:10.1371/journal.pone.0005106.g006
Figure 5. Role of calcium entry in the action of sucralose on [Ca
2+]c. (A) Epac1-camps-expressing MIN6 cells loaded with fura-2 were
stimulated by 50 mM sucralose in calcium-free HBSS, and changes in [Ca
2+]c (#) and [cAMP]c (N) were monitored. (B) Epac1-camps-expressing MIN6
cells loaded with fura-2 were stimulated by 50 mM sucralose in the presence of 1 mM nifedipine. (C) Epac1-camps-expressing MIN6 cells loaded with
fura-2 were incubated in Na-free HBSS and stimulated with 50 mM sucralose and changes in [Ca
2+]c (#) and [cAMP]c (N) were measured. (D) Epac1-
camps-expressing MIN6 cells loaded with fura-2 were stimulated with 50 mM sucralose in the presence of 200 mM 2APB and changes in [Ca
2+]c (#)
and [cAMP]c (N) were measured. (E) Quantitative analysis of the above data. *: P,0.05. (F) Expression of TRPM channels in MIN6 cells. Expression of
various types of TRPM channels was measured by RT-PCR using mRNA obtained from MIN6 cells. 1, 2, 3, 4, 5, 6, 7, and 8 stand for TRPM1, TRPM2,
TRPM3, TRPM4, TRPM5, TRPM6, TRPM7, TRPM8, respectively.
doi:10.1371/journal.pone.0005106.g005
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and succharin may cause depolarization.
We investigated the intracellular signaling system activated by
the sweet taste receptor in MIN6 cells. We monitored changes in
[Ca
2+]c and [cAMP]c in living MIN6 cells using a fluorescent
indicator fura-2 and fluorescent proteins GFP, CFP and YFP. The
results show that sucralose increased both [Ca
2+]c and [cAMP]c,
and in addition, induced phosphorylation of PKC substrate
MARCKS. Indeed, sucralose increased [Ca
2+]c by inducing
mobilization of calcium from an intracellular pool and also
stimulation of calcium entry. Since mobilization of calcium was
blocked by an inhibitor of the Ins-P3 receptor 2APB (13), it is likely
that the sweet taste receptor agonist sucralose activates PLC in
MIN6 cells. Nevertheless, the effects of sucralose on [Ca
2+]c and
Figure 7. Expression of the sweet receptor in islets. (A) Expression of mRNA in Mouse Islets. mRNA was extracted from mouse islets and the
expression of T1R2, T1R3, and Gagust was measured by RT-PCR. (B) Comparison of the Expression of T1Rs and Gustducin in Islets and MIN6 cells.
mRNA levels for T1R2 (a), T1R3 (b) and Gagust (c) were measured by quantitative PCR in islets and MIN6 cells and expressed as relative to b actin. (C)
Expression of T1R3 in Islets. Pancreatic slices were stained with anti-T1R3 (a) and anti-insulin (b) antibodies. c: merge. (D) Effects of Artificial
Sweeteners on Insulin secretion from Islets. Islets were incubated for 60 min with various concentrations of sucralose in the presence of 2.8 and
20 mM glucose. Values are the mean6S.E. for four experiments. *: p,0.05 vs control.
doi:10.1371/journal.pone.0005106.g007
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mobilizing agonists such as carbachol, which activates PLC via
an activation of Gq. For example, a muscarinic agonist carbachol
activates PLC-b and increases [Ca
2+]c by causing calcium release
via the Ins-P3 receptor and stimulation of calcium entry. Unlike
sucralose, however, carbachol instead reduced [cAMP]c. This may
have been due to an activation of Gi by the muscarinic receptor. In
contrast, sucralose significantly increased [cAMP]c. These results
suggest that the sweet taste receptor activated PLC-b by a different
mechanism compared to carbachol. Consistent with this notion,
sucralose-induced effects on [Ca
2+]c and [cAMP]c were not
affected by a Gq/11 inhibitor YM254890, while YM254890
completely abolished the carbachol effects. Consequently, it is
likely that sucralose may activate PLC by a mechanism
independent of Gq activation. In the taste buds, the sweet taste
receptor is coupled to gustducin, which is also expressed in MIN6
cells. We therefore speculate that the sweet taste receptor is also
coupled to gustducin in MIN6 cells. In this regard, [Ca
2+]c.
response induced by sucralose was inhibited by gurmarin.
Gurmarin is an inhibitor of the sweet taste receptor and is thought
to affect the activation of gustducin by T1R2 + T1R3 in the tast
buds [12]. Collectively, it is conceivable that at least some of the
signals generated by the sweet taste receptor in MIN6 cells are
mediated by gustducin. With regard to an increase in cAMP
induced by sucralose, the present results show that most of the
cAMP signal was inhibited by reduction of calcium entry.
Calcium-dependent activation of adenylate cyclase and/or
inhibition of phosphodiesterase may have been involved. Howev-
er, some increase was observed in [cAMP]c even in the presence of
2APB, which completely blocked sucralose-induced elevation of
[Ca
2+]c. This raises a possibility that activation of the sweet taste
receptor also increases [cAMP]c by a calcium-independent
mechanism possibly through Gs.
The results shown in Figure 5A indicate that sucralose-mediated
elevation of [Ca
2+]c was greatly dependent on extracellular
calcium. Also, nifedipine markedly reduced elevation of [Ca
2+]c
induced by sucralose. It is likely that sucralose eventually activated
the voltage-dependent calcium channel and augmented calcium
entry. In this regard, removal of extracellular sodium blocked
calcium entry induced by sucralose. Sucralose may activate
sodium-permeable cation channel and depolarizes the plasma
membrane, which leads to the activation of the voltage-dependent
calcium channel. In the taste buds of the tongue, the sweet taste
receptor activates TRPM5 and induces sodium entry, which is a
prerequisite for sweet sensation [15]. As shown in Figure 5F,
TRPM5 is not expressed in MIN6 cells. It seems likely that other
members of the TRP family may be involved in the action of
sucralose. In this regard, TRPM2 and TRPM4 are expressed in
MIN6cells.TRPM4isasodium-permeablecationchannelactivated
by Ca
2+ and is involved in the regulation of insulin secretion (20).
TRPM2 is a calcium-permeable channel and is involved in insulin
secretion [21]. Further studies are necessary to determine the
involvement of these channels in the action of sucralose.
The present results show that the sweet taste receptor is
expressed in b-cells and is functionally operative. In addition to the
taste buds in the tongue [1–4] and enteroendocrine cells [8],
pancreatic b-cells express the sugar-sensing receptor system. At
present, the physiological role of the sweet taste receptor in b-cells
is not clear. The obvious candidate ligand for this receptor is
glucose. However, the patterns of the changes in intracellular
signals generated by high concentration of glucose (Figure 3C) and
sucralose (Figure 3A) are quite different. Furthermore, the effect of
glucose on [Ca
2+]c is blocked by diazoxide, whereas the effect of
sucralose is not affected by diazoxide. Most of the signals
generated by high concentration of glucose may be independent
of the sweet taste receptor. Then the question is what is a natural
ligand for the taste receptor expressed in b-cells? Given that the
sweet taste receptor is able to be activated by a variety of
compounds with different structures, it is tempting to speculate
that an endogenous ligand(s) for the sweet taste receptor other
than glucose may exist, and it modifies the b-cell functions through
activation of the sweet taste receptor. Further studies are required
to address this issue. From a practical point of view, the present
study raises an interesting possibility that agonists for the sweet
taste receptor may be good therapeutic candidates to augment
insulin secretion. For this purpose, the putative compounds or
artificial sweeteners should be absorbed efficiently as an intact
molecule and should have access to b-cells via circulation. Since
artificial sweeteners are not fuel, they provide insulin secretagogues
without affecting the metabolism. Given that sweet taste receptor
agonists increase calcium and especially cAMP in b-cells, they can
be useful stimulators of insulin secretion. In this regard, it should
be mentioned that sucralose is an artificial sweetener and used as a
noncaloric sweeteners to reduce the intake of sugars. It is shown
that the compound does not affect the glycemic control in diabetic
patients [22,23]. However, since sucralose increases insulin
secretion in a dose-dependent manner, high dose of the compound
may aggravate hypoglycemia.
Materials and Methods
Cell Culture
MIN6 cells (passages 16–24) [24] were grown in Dulbecco’s
modified Eagle’s medium containing high glucose (Invitrogen,
Carlsbad, CA) and 15% fetal bovine serum and cultured in a
humidified incubator 95% air and 5% CO2 at 37uC.
Isolation of Total RNA and Quantitative RT–PCR
Total RNA of MIN6 cells was isolated by using the TRIZOL
Reagent (Invitrogen), and that of mice islets was isolated by using
the RNeasy Mini Kit (Qiagen, Valencia, CA). Then these total
RNAs were used for cDNA synthesis using Superscript II reverse
transcriptase (Invitrogen), random primer (Takara Bio, Inc., Shiga,
Japan) and oligo (dT)
12–18 (Invitrogen). Quantitative RT-PCR was
performed with 7500 Fast Real-Time PCR System (Applied
Biosystems, Foster City, CA). The PCR reaction mixture consisted
of first-strand cDNA template, SYBR GREEN PCR Master Mix
(Applied Biosystems) and primer sets. For T1R2, the forward
primer was 59-GTCCGCTGCACCAAGCA-39 and the reverse
primer was 59-GTTCGTCGAAGAAGAGCTGGTT-39. For
T1R3, the forward primer was 59-TCAGAGCTTGCCCTCAT-
TACAG-39 and the reverse primer was 59-TGTGCGGAA-
GAAGGATGGA-39. For Gagust, the forward primer was 59-
TGCATTATATTTTGCGCAGC-39 and the reverse primer was
59- AGAACAATGGAGGTGGTTGC-39. For b-actin, the for-
ward primer was 59-AGGATGCAGAAGGAGATTACTG-39
and the reverse primer was 59- GCRGATCCACATCTGCTG-
GAA-39. In all cases, expression was corrected with that of b-actin
measured on the same sample in parallel on the same plate.
RT–PCR
Total RNA isolated from MIN6 cells and mice islets was used
for cDNA synthesis using Superscript III reverse transcriptase
(Invitrogen) and oligo (dT)
12–18. The cDNA was used for PCR
template using Taq DNA Polymerase, recombinant (Invitrogen)
and the following primer sets: For T1R2 mRNA, the forward
primer was 59-CACGATGAGGAAGAGCTAGTC-39 and the
reverse primer was 59-CACCCAAGGGAAATTTATTCATA-39.
Sweet Taste Receptor in Islet
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TACTGGCCAGGCAAC-39 and the reverse primer was 59-
GTGAGCCATTGGTTGTTGTG-39. For Gagust mRNA, the
forward primer was 59-CTGGTATCATTGAAACTCAATT-
CTCC-39 and the reverse primer was 59-GAGCCCACAG-
TCTTTGAGGTTC-39. For control GAPDH mRNA, the
forward primer was 59-ATGGGAAGCTGGTCATCAAC-39
and the reverse primer was 59-GGATGCAGGGATGATG-
TTCT-39. For TRPM1 mRNA, the forward primer was 59-
ATCCGAGTCTCCTACGACACCAAG -39 and reverse primer
was 59- TCTTTCAAGGCATCCCCCAC-39. For TRPM2
mRNA, the forward primer was 59-CCAATCTCCGACGAAG-
CAATAG-39 and reverse primer was 59- GCTCAGGTCTGT-
GAAAACGATGTC-39. For TRPM3 mRNA, the forward primer
was 59-CGTGGGGGACCGTTTATTTTC-39 and reverse prim-
er was 59- GAAGCACAGAGATACTGGGAGTGAG-39. For
TRPM4 mRNA, the forward primer was 59-GCTTTCG-
TGCCCCAAACTTG-39 and reverse primer was 59-
TTCTGCTGAGCCACATAGGACTC-39. For TRPM5 mRNA,
the forward primer was 59-GGAAGAAGCGAGGCAAGTTTG-
39 and reverse primer was 59- GAAGTTGACGGTGAAG-
GATTCG-39. For TRPM6 mRNA, the forward primer was 59-
GAAGCACACAGTGAAAAGCCCTAC-39 and reverse primer
was 59- GGTTCTCAATGACTCCCCAAGG-39. For TRPM7
mRNA, the forward primer was 59-TCCAGGATGTCA-
GATTTGTCAGC-39 and reverse primer was 59- CTGTAG-
GAATGAGAACCCCCTTG-39. For TRPM8 mRNA, the for-
ward primer was 59-ATGAGGAGCCGCAGAAATGG-39 and
reverse primer was 59- CCAGGTTGGGTGTTTTGAGGTG-39.
Transfection
Cells were transiently transfected with 5.4 mg of plasmid
encoding Epac1-camp [25] or MARCKS-GFP [26] using
Lipofectamine 2000 transfection reagent (Invitrogen) according
to the manufacturer’s instructions. Transfection efficiencies ranged
between 70 and 80%.
Imaging of Epac1-camps, MARCKS-GFP, and Fura-2
Transfected MIN6 cells were placed on a 35 mm glass bottom
culture dish. Before the measurements, growth medium was
removed and replaced with Hanks’ balanced salt solution (HBSS)
containing 1.3 mM CaCl2, 5.4 mM KCl, 0.44 mM KH2PO4,
0.5 mM MgCl2, 0.38 mM MgSO4, 138 mM NaCl, 0.34 mM
Na2HPO4, 3.0 mM D-glucose and HEPES-NaOH (pH 7.4). To
remove extracellular sodium, sodium was replaced by choline
chloride. For imaging, cells were visualized with a 40 Uapo/340
objective lens (Olympus, Tokyo, Japan). The Epac1-camps
excitation wavelength was 440 nm and attenuated by 6% using
neutral density filters. For dual emission ratio imaging for
enhanced cyan fluorescent protein (ECFP) and enhanced yellow
fluorescent protein (EYFP), we used AQUACOSMOS/
ASHURA, a 3CCD based fluorescence energy transfer imaging
system (Hamamatsu Photonics, Hamamatsu, Japan). MARCKS-
GFP [26] fluorescence was obtained by excitation at 488 nm.
Images (200–300 ms exposure) were captured with a 12-bit
C7780-22 ORCA3CCD camera (Hamamatsu Photonics) at 10 s
intervals. Epac1-camps FRET was decreased with increasing
cAMP concentration: an increase in the FRET emission ratio is
indicative of an increase in cytoplasmic cAMP concentration
([cAMP]c) [25]. Fluorescence intensity in the cytosol of the cells
expressing MARCKS-GFP was also measured. These values (F)
were normalized to each initial value (F0) so that the relative
fluorescence change was referred to as F/F0.
For simultaneous measurements of intracellular Ca
2+ and
cAMP levels or intracellular Ca
2+ and MARCKS-GFP transloca-
tion, we used fura-2 to detect cytoplasmic Ca
2+ concentration
([Ca
2+]c) [27]. Spectral separation of Epac1-camps and fura-2 or
MARCKS-GFP and fura-2 excitation and emission permits
simultaneous imaging of [cAMP]c and [Ca
2+]c or MARCKS-
GFP and [Ca
2+]c in a single cell. For concurrent [cAMP]c and
[Ca
2+]c or MARCKS-GFP and [Ca
2+]c measurements, MIN6
cells transiently transfected with Epac1-camps or MARCKS-GFP
were loaded with 1.5 mM fura-2/AM (Dojindo, Kamimashiki,
Japan) for 20 min at room temperature. Excitation filters of 340-
and 380-nm and a 530-nm emission filter were used for fura-2
dual excitation ratio imaging. A U-MGFPHQ fluorescence mirror
unit (Olympus) was used for MARCKS-GFP. Imaging data
acquisition and analysis were accomplished using Aquacosmos 2.6
software (Hamamatsu Photonics). Excitation filters of 340- and
380-nm were used for fura-2 dual excitation and these images
were obtained by yellow channel of the 3CCD camera. The
backgrounds of the emission intensities were subtracted. Data are
expressed as the ratio of FRET cyan channel and yellow channel
intensity, the ratio of fura-2 340 and 380 nm excitation (340/380
ratio) and the ratio of MARCKS-GFP cytosolic fluorescence
intensity and initial intensity (F/F0). In addition, data were
normalized to the average base-line values of the 485/535 and
340/380 nm ratio (485/535 and 340/380 nm relative ratio,
respectively) to facilitate comparisons between responses in
different cells. Data are expressed as means6S.E.
Animals
C57BL/6J mice were purchased from CLEAR Japan (Tokyo,
Japan). They were kept in an experimental animal facility
controlled at 23uC room temperature with a 12-hr light and dark
cycle, and with free access to standard chow and water.
The animal experiment was conducted according to the
guidelines for animal care issued by The Animal Experiment
and Ethic Committee, Gunma University, School of Medicine.
Histology and Immunohistochemistry
Male C57BL/6J mice were anesthetized with ether. Pancreata
were excised and fixed in Bouin’s fixative at 4uC overnight. The
pancreata were embedded in paraffin, and serial holizontal
sections of 5 mm were cut, deparaffinized, and immunofluores-
cence was performed as described previously [28]. Antigen
retrieval consisted of treatment of paraffin sections three times
for 5 min each with 0.01M citrate buffer in a microwave oven,
followed by a 20 min cool-down period before proceeding to the
next step. For immunohistochemistry, sections were treated with
1% bovine serum albumin (BSA) in phosphate-buffered saline
(PBS) for 30 min to block nonspecific antibody binding. The
following primary antibodies were diluted with PBS containing 1%
BSA and applied to the sections: rabbit polyclonal anti-G Protein-
Coupled Receptor TAS1R2 antibody (1:100, LifeSpan Bioscienc-
es, Seattle, WA), rabbit polyclonal anti-G Protein-Coupled
Receptor TAS1R3 antibody (1:100, MBL International Corpora-
tion, Woburn, MA), rabbit polyclonal anti-glucagon antibody
(1:500; DAKO, Carpenteria, CA), and guinea pig polyclonal anti-
insulin antibody (1:1,000; DAKO). For enzymatic detection of the
bound primary antibodies, Alexa Fluor 488-conjugated anti-rabbit
IgG, Alexa Fluor 568-conjugated anti-guinea pig IgG, and Alexa
Fluor 568-conjugated anti-rabbit IgG (Molecular Probes, Oregon)
were used at 1:200 dilution (PBS with 1% BSA). Nuclear
counterstaining was achieved by 49, 6-Diamidino-2-phenylin-
dole-HCl (DAPI) (PIERCE, Rockford, IL). Immunocytochemical
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microscope FV1000-D (OLYMPUS, Tokyo, Japan).
Immunofluoresence Microscopy of Cultured Cells
MIN6 cells grown on the micro cover glass (MATSNAMI
Glass., ltd., Tokyo, Japan) were fixed with 3% paraformaldehyde
over night at 4uC. Fixed cells were incubated in Glycine/PBS
(containing 50 mM glycine ) for 3 min and subsequently incubated
in PBS-T (containing 0.1% v/v Triton X-100 ) for 5 min at room
temperature. Cells were then incubated overnight at 4uC with
either T1R2 antibody or T1R3 antibody, each used at a dilution
of 1:800. After 3 times washing with PBS, cells were incubated
with the Alexa 488-conjugated secondary antibody (dilution;
1:1000, In Vitrogen) and DAPI (dilution; 1:1000) for 1 hour at
room temperature. All of the presented images were captured
using confocal laser scanning biological microscope FV1000-D
(OLYMPUS).
Evaluation of Insulin Secretion
MIN6 cells were seeded into 24-well plates and incubated for
48–72 h before measurement of insulin secretion. Cells were
preincubated for 1h in Krebs-Ringer-HEPES (KRH) buffer
(125 mM NaCl, 5.9 mM KCl, 1.28 mM CaCl2, 5.0 mM
NaHCO3, 25 mM HEPES/NaOH, and 0.1% (w/v) bovine serum
albumin) in a 37uC humidified incubator [29]. The cells were then
incubated in the same buffer containing 2.8, 8.3 or 25 mM glucose
in the presence and absence of artificial sweeteners. The
supernatant of the cells was collected and centrifuged at 300 g
for 10 min to remove cell debris. The insulin concentration in the
supernatant was measured by radioimmunoassay (Eiken Chemi-
cal, Tokyo, Japan) according to the manufacturer’s protocol. The
insulin secretion data were normalized by insulin content. Mouse
islets were isolated by collagenase digestion [30] and were
preincubated for 1 h in KRH buffer. Then the islets were
incubated for 1 h in KRH buffer containing various compounds.
The supernatant was collected and the insulin concentration was
measured.
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